Abstract:Ubiquitin-like proteins (UBLs) constitute a family of evolutionarily conserved proteins that share similarities with ubiquitin in 3D structures and modification mechanisms. For most UBLs including Small-Ubiquitin-like Modifiers (SUMO), their modification sites on substrate proteins cannot be identified using the mass spectrometry-based method that has been successful for identifying ubiquitination sites, unless a UBL protein is mutated accordingly. To identify UBL modification sites without having to mutate UBL, we have developed a dedicated search engine pLink-UBL on the basis of pLink, a software tool for identification of cross-linked peptide pairs. pLink-UBL exhibited superior precision, sensitivity, and speed than make-do search engines such as MaxQuant, pFind, and pLink. For example, compared to MaxQuant, pLink-UBL increased the number of identified SUMOylation sites by 50 ~ 300% from the same datasets. Additionally, we present a method for identifying small-molecule modifications of UBLs. This method involves antibody enrichment of a UBL C-terminal peptide following enrichment of a UBL protein, followed by LC-MS/MS analysis and a pFind 3 blind search to identify unexpected modifications. Using this method, we have discovered non-protein substrates of SUMO, of which spermidine is the major one for fission yeast SUMO Pmt3. Spermidine can be conjugated to the C-terminal carboxylate group of Pmt3 through its N1 or also likely, N8 amino group in the presence of SUMO E1, E2, and ATP. Pmt3-spermidine conjugation does not require E3 and can be reversed by SUMO isopeptidase Ulp1. SUMO-spermidine conjugation is present in mice and humans. Also, spermidine can be conjugated to ubiquitin in vitro by E1 and E2 in the presence of ATP. The above observations suggest that spermidine may be a common small molecule substrate of SUMO and possibly ubiquitin across eukaryotic species.

Proteome-wide Mapping of Endogenous SUMOylation Sites in Mouse Testis.

Antibody-free enrichment method for proteome-wide analysis of endogenous SUMOylation sites

Site-specific identification and quantitation of endogenous SUMO modifications under native conditions

Site-specific identification and quantitation of endogenous SUMOylation based on SUMO-specific protease and strong anion exchange chromatography

Identification and analysis of endogenous SUMO1 and SUMO2/3 targets in mammalian cells and tissues using monoclonal antibodies

Global Screening of Sentrin-Specific Protease Family Substrates in SUMOylation

Monoclonal antibody-based systematic identification of SUMO1-modification sites reveals TFII-I SUMOylation is involved in tumor growth

A genome-wide analysis of sumoylation-related biological processes and functions in human nucleus.

Systematic in-depth proteomic analysis of mitochondria-associated endoplasmic reticulum membranes (MAM) in mouse and human testes.

Ms-Based Strategies For Identification Of Protein Sumoylation Modification

Highly sensitive site-specific SUMOylation proteomics in Arabidopsis

The Strategies for Identification and Quantification of SUMOylation

A Method For Sumo Modification Of Proteins In Vitro

In Vivo Detection and Analysis of Rb Protein SUMOylation in Human Cells.

In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity

Systematic Study of Protein Sumoylation: Development of a Site-Specific Predictor of SUMOsp 2.0.

Sensitive detection of intracellular sumoylation via SNAP tag-mediated translation and RNA polymerase-based amplification.

Development and Evaluation of a Highly Reliable Assay for SUMO-Specific Protease Inhibito R S

Global analysis of protein and small-molecule substrates of ubiquitin-like proteins (UBLs)

SUMOylation Activates Large Tumour Suppressor 1 to Maintain the Tissue Homeostasis During Hippo Signalling

Important Role of SUMOylation of Spliceosome Factors in Prostate Cancer Cells.